Tumor-infiltrating lymphocytes make inroads in non-small-cell lung cancer.
Tumor-infiltrating lymphocytes make inroads in non-small-cell lung cancer.
复制标题
肿瘤浸润淋巴细胞侵入非小细胞肺癌。
DOI：
10.1038/s41591-021-01445-z
复制
发表时间：
2021
期刊：
影响因子：
82.9
通讯作者：
Riddell,StanleyR
中科院分区：
文献类型：
--
作者：
Veatch,JoshuaR;Simon,Sylvain;Riddell,StanleyR
一项1期试验显示，肿瘤浸润淋巴细胞疗法在晚期非小细胞肺癌患者中具有良好的抗肿瘤活性。
A phase 1 trial shows promising anti-tumor activity of tumor-infiltrating-lymphocyte therapy in patients with advanced non–small-cell lung cancer.